![Marika Geissler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Marika Geissler has worked as the Chief of Operations at GEMoaB Monoclonals GmbH since 2015.
Marika Geissler active positions
Companies | Position | Start |
---|---|---|
GEMoaB Monoclonals GmbH
![]() GEMoaB Monoclonals GmbH Pharmaceuticals: MajorHealth Technology Part of AvenCell Therapeutics, Inc., GEMoaB Monoclonals GmbH is a German company that manufactures biopharmaceutical products. The company is based in Dresden, Germany. The company was founded in 2014 by Gerhard Ehninger. GEMoaB Monoclonals was acquired by AvenCell Therapeutics, Inc. from Cellex Cell Professionals GmbH on March 30, 2022. | Chief Operating Officer | 2014-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
GEMoaB Monoclonals GmbH
![]() GEMoaB Monoclonals GmbH Pharmaceuticals: MajorHealth Technology Part of AvenCell Therapeutics, Inc., GEMoaB Monoclonals GmbH is a German company that manufactures biopharmaceutical products. The company is based in Dresden, Germany. The company was founded in 2014 by Gerhard Ehninger. GEMoaB Monoclonals was acquired by AvenCell Therapeutics, Inc. from Cellex Cell Professionals GmbH on March 30, 2022. | Health Technology |
- Stock Market
- Insiders
- Marika Geissler